March 17, 2024 by Lari Harding
DIR reform in 2024: One step forward, two steps back
March 18, 2024, Pharmacy
Direct and indirect remuneration was initiated with best intentions. DIR was originally introduced to create a pharmacy reimbursement model wherein payers would reimburse pharmacies based on patient outcomes, a pay-for-performance model. It included adherence measures and the use of generic drugs so that pharmacies would focus on better outcomes and lower costs — otherwise known
March 17, 2024 by Geoff Walden
Emerson team is optimizing retailers’ digital efforts
March 18, 2024, Supplier News
BONITA SPRINGS, Fla. — The emerging leaders of the Emerson Group are bringing their digital commerce expertise to retailers. The team was selected by founder and president Scott Emerson, and the members have honed their e-commerce skills with CPG brands. Now they want to enable retailers — like the ones they spoke to at the
March 17, 2024 by Chain Drug Review
First Quality continues to invest in clinical support
March 18, 2024, Supplier News
GREAT NECK, N.Y. — With more consumers turning to retail pharmacies as a resource for their health care needs, First Quality continues to invest in its clinical support services to provide education and support on incontinence, menstrual care and baby care. The clinical support reflects First Quality’s heritage in the health care industry, which began
March 17, 2024 by Bill Schiffner
Listerine Clinical Solutions addresses variety of concerns
March 18, 2024, Supplier News
SKILLMAN, N.J. — Last fall, Kenvue Inc., the world’s largest pure-play consumer health company by revenue, announced a major extension to its Listerine line with Listerine Clinical Solutions. The new lineup includes: Listerine Clinical Solutions Antiseptic Gum Health Mouthwash, Clinical Solutions Breath Defense Mouthwash and Clinical Solutions Teeth Strength – Mouthwash. “As the No. 1
March 17, 2024 by Jeffrey Woldt
Need to fix DIR points to bigger challenge
March 18, 2024, Opinion
At the beginning of the month, retail pharmacy advocates were engaged in a full-court press to convince members of Congress, who were locked in a protracted battle over federal spending and a possible government shutdown, to include meaningful PBM reform in a final budget deal. A coalition of industry groups urged lawmakers to enact what
March 17, 2024 by David Pinto
Chain drug retailing may never see another Turley
March 18, 2024, Opinion
Stew Turley passed away last month, a victim of deteriorating health and advancing age. To those who knew and worked with Turley, no explanation of the man’s impact and influence on chain drug retailing in America during the last half of the 20th century would suffice to explain the impact the news of his passing
February 19, 2024 by Trey Holder
Firework’s Cladek discusses digital store enhancements
February 19, 2024, Supplier News
NEW YORK — The Agile Innovation Series focuses on the need for organizations to constantly evolve and innovate with an agile mind-set to remain viable in today’s dynamic world. Throughout the series accelerate360’s Trey Holder explores the current business environment through interviews with leaders in a variety of fields. This month, Holder caught up with
February 19, 2024 by Bill Schiffner
Hallmark, Venmo continue to transform gift-giving
February 19, 2024, Supplier News
KANSAS CITY — In 2024, Hallmark will continue to build on the popularity of Hallmark + Venmo Cards. These new cards offer a unique and convenient way of gifting to friends and family. “With this recently launched, first-of-its kind collaboration, customers can now securely send money with Venmo in a physical Hallmark card. By bringing
February 19, 2024 by Brittne Kakulla
Older adults embrace technology but are wary of AI
February 19, 2024, Technology
Younger adults don’t have a corner on the tech market — far from it. A new AARP survey finds that older Americans are about as likely as those under age 50 to own a smartphone, tablet or other device. Nearly nine out of 10 Americans (89% of those 50-plus and 90% of those 18 to
February 19, 2024 by Chain Drug Review
Proffitt on Dr. Reddy’s private label O-T-C business
February 19, 2024, Pharmacy
Lindsay Proffitt, who runs the private label over-the-counter drug business at Dr. Reddy’s, spoke with Chain Drug Review about her role, the significance of store brands for the company and the opportunities they present. CDR: What is your title and what are your responsibilities? PROFFITT: My title is head of private label O-T-C product management,
February 19, 2024 by Jeffrey Woldt
Staying consumer-centric in a digital world
February 19, 2024, Opinion
“The future is purchased by the present,” wrote Samuel Johnson in one of his essays for The Rambler. That idea was reflected during a panel discussion at last month’s FMI Midwinter Conference. Members of the group — which included David Best, president and chief operating officer of Coborn’s Inc.; Sandy Douglas, chief executive officer of
February 19, 2024 by David Pinto
Five reasons regional drug chains lead the industry
February 19, 2024, Opinion
On the eve of the annual NACDS regional chain conference, about to convene in South Florida as this piece is written, now is perhaps the perfect time to reflect on the stunning success regional drug chains are experiencing in the U.S. chain drug community. For openers, it is simpler to evaluate the small chain segment
February 19, 2024 by Melanie Nelson
Key challenges in chemicals and materials R&D, Melanie Nelson
February 19, 2024, Pharmacy
The chemical and materials industry contributes roughly $5.7 trillion to global GDP (gross domestic product) and supports an estimated 120 million jobs, according to a recent report published by the International Council of Chemical Associations. To meet massive demand, chemicals and materials research and development teams face many challenges, including the need to move at
February 5, 2024 by Bill Schiffner
Lifelab’s new HoneyWorks Plus offers ‘more with less’
February 5, 2024, Supplier News
COCONUT CREEK, Fla. — The cold and flu category continues to grow as people return to work in offices across the country, noted Lou Machin, managing director at Lifelab Health. “There is a trend to over-medicate as office workers are experiencing ‘sick shaming’ due to continuing concerns over COVID variants on the scene,” he pointed